| 3149 |
177: Increase, Mitochondrial dysfunction |
1263: Necrosis |
Mar 13, 2024 |
Mar 13, 2024 |
1 AOP
|
| 3150 |
177: Increase, Mitochondrial dysfunction |
1762: cell injury |
Mar 13, 2024 |
Mar 13, 2024 |
1 AOP
|
| 3152 |
177: Increase, Mitochondrial dysfunction |
1817: Apoptotic cell death |
Mar 13, 2024 |
Mar 13, 2024 |
1 AOP
|
| 3153 |
177: Increase, Mitochondrial dysfunction |
1815: Increase, ER stress |
Mar 13, 2024 |
Mar 13, 2024 |
1 AOP
|
| 3155 |
177: Increase, Mitochondrial dysfunction |
833: Occurrence, Cytoplasmic vacuolization (hepatocyte) |
Mar 13, 2024 |
Mar 13, 2024 |
1 AOP
|
| 3156 |
177: Increase, Mitochondrial dysfunction |
835: Occurrence, Ballooning degeneration (hepatocyte) |
Mar 13, 2024 |
Mar 13, 2024 |
1 AOP
|
| 3157 |
177: Increase, Mitochondrial dysfunction |
837: Occurrence, Cytoplasmic vacuolization (kupffer cell) |
Mar 13, 2024 |
Mar 13, 2024 |
1 AOP
|
| 3158 |
177: Increase, Mitochondrial dysfunction |
836: Occurrence, Cytoplasmic vacuolization (Bile duct cell) |
Mar 13, 2024 |
Mar 13, 2024 |
1 AOP
|
| 3161 |
177: Increase, Mitochondrial dysfunction |
2144: Impaired insulin signaling |
Mar 13, 2024 |
Mar 13, 2024 |
1 AOP
|
| 3164 |
177: Increase, Mitochondrial dysfunction |
1917: Altered expression of NRF2 pathway-dependent genes |
Mar 14, 2024 |
Mar 14, 2024 |
1 AOP
|
| 3165 |
177: Increase, Mitochondrial dysfunction |
202: Inhibition, Nuclear factor kappa B (NF-kB) |
Mar 14, 2024 |
Mar 14, 2024 |
1 AOP
|
| 2797 |
2072: Increase, Mitochondrial swelling |
55: Cell injury/death |
Nov 1, 2022 |
Nov 1, 2022 |
1 AOP
|
| 198 |
350: Increase, Mortality |
328: Decrease, Fecundity |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 199 |
350: Increase, Mortality |
361: Decline, Population |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1004 |
350: Increase, Mortality |
765: Decreased, population 1 |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1013 |
350: Increase, Mortality |
997: Decreased, Population size |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 2463 |
350: Increase, Mortality |
360: Decrease, Population growth rate |
Aug 5, 2021 |
Aug 5, 2021 |
None
|
| 991 |
962: Increase, Mucin production |
943: Hypersecretion, Mucus |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1315 |
962: Increase, Mucin production |
1251: Chronic, Mucus hypersecretion |
Nov 29, 2016 |
Aug 30, 2021 |
None
|
| 2859 |
962: Increase, Mucin production |
1250: Decreased lung function |
Mar 15, 2023 |
Mar 16, 2023 |
1 AOP
|
| 1486 |
1374: Increase, mucosal blood flow |
1380: Activate, mucosal defense |
Apr 17, 2017 |
Apr 17, 2017 |
1 AOP
|
| 1485 |
1373: Increase, mucous |
1380: Activate, mucosal defense |
Apr 17, 2017 |
Apr 17, 2017 |
1 AOP
|
| 202 |
185: Increase, Mutations |
336: Increase, Heritable mutations in offspring |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 899 |
185: Increase, Mutations |
885: Increase, Cancer |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 1896 |
185: Increase, Mutations |
1182: Increase, Cell Proliferation (Epithelial Cells) |
May 7, 2019 |
May 8, 2019 |
2 AOPs
|